Literature DB >> 28035592

Research Participants' Preferences for Hypothetical Secondary Results from Genomic Research.

Julia Wynn1, Josue Martinez1, Jimmy Duong2, Codruta Chiuzan2, Jo C Phelan3, Abby Fyer4, Robert L Klitzman4, Paul S Appelbaum4, Wendy K Chung5,6.   

Abstract

Secondary or incidental results can be identified in genomic research that increasingly uses whole exome/genome sequencing. Understanding research participants' preferences for secondary results and what influences these decisions is important for patient education, counseling, and consent, and for the development of policies regarding return of secondary results. Two hundred nineteen research participants enrolled in genomic studies were surveyed regarding hypothetical preferences for specific types of secondary results, and these preferences were correlated with demographic information and psychosocial data. The majority of research participants (73%) indicated a preference to learn about all results offered, with no clear pattern regarding which results were not desired by the remaining participants. Participants who reported greater interest in genetic privacy were less likely to indicate a preference to learn all results, as were individuals who self-identified as Jewish. Although most research participants preferred to receive all secondary results offered, a significant subset preferred to exclude some results, suggesting that an all-or-none policy would not be ideal for all participants. The correlations between preferences to receive secondary results, religious identification, and privacy concerns demonstrate the need for culturally sensitive counseling and educational materials accessible to all education levels to allow participants to make the best choices for themselves.

Entities:  

Keywords:  Genomics; Incidental findings; Incidental results; Return of results; Secondary findings; Secondary results; Whole exome sequencing

Mesh:

Year:  2016        PMID: 28035592     DOI: 10.1007/s10897-016-0059-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  Factors associated with decisions about clinical BRCA1/2 testing.

Authors:  K Armstrong; K Calzone; J Stopfer; G Fitzgerald; J Coyne; B Weber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

2.  The association between knowledge and attitudes about genetic testing for cancer risk in the United States.

Authors:  Abigail Rose; Nikki Peters; Judy A Shea; Katrina Armstrong
Journal:  J Health Commun       Date:  2005-06

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

5.  Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.

Authors:  A A Lemke; D Bick; D Dimmock; P Simpson; R Veith
Journal:  Clin Genet       Date:  2012-12-07       Impact factor: 4.438

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Association of Researcher Characteristics with Views on Return of Incidental Findings from Genomic Research.

Authors:  Julia Wynn; Josue Martinez; Jimmy Duong; Yuan Zhang; Jo Phelan; Abby Fyer; Robert Klitzman; Paul S Appelbaum; Wendy K Chung
Journal:  J Genet Couns       Date:  2015-01-17       Impact factor: 2.537

8.  Informed consent for return of incidental findings in genomic research.

Authors:  Paul S Appelbaum; Cameron R Waldman; Abby Fyer; Robert Klitzman; Erik Parens; Josue Martinez; W Nicholson Price; Wendy K Chung
Journal:  Genet Med       Date:  2013-10-24       Impact factor: 8.822

9.  Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.

Authors:  G Hegwer; C Fairley; J Charrow; K E Ormond
Journal:  J Genet Couns       Date:  2006-02       Impact factor: 2.717

10.  Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public.

Authors:  Saskia C Sanderson; Sabrina A Suckiel; Micol Zweig; Erwin P Bottinger; Ethylin Wang Jabs; Lynne D Richardson
Journal:  Genet Med       Date:  2015-09-03       Impact factor: 8.822

View more
  19 in total

Review 1.  Clinical utility of genomic sequencing.

Authors:  Matthew B Neu; Kevin M Bowling; Gregory M Cooper
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

2.  Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences.

Authors:  Michelle L McGowan; Cynthia A Prows; Melissa DeJonckheere; William B Brinkman; Lisa Vaughn; Melanie F Myers
Journal:  J Empir Res Hum Res Ethics       Date:  2018-05-28       Impact factor: 1.742

3.  A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.

Authors:  Allison L Cirino; Neal K Lakdawala; Barbara McDonough; Lauren Conner; Dale Adler; Mark Weinfeld; Patrick O'Gara; Heidi L Rehm; Kalotina Machini; Matthew Lebo; Carrie Blout; Robert C Green; Calum A MacRae; Christine E Seidman; Carolyn Y Ho
Journal:  Circ Cardiovasc Genet       Date:  2017-10

4.  Prior opioid exposure influences parents' sharing of their children's CYP2D6 research results.

Authors:  Melanie F Myers; Xue Zhang; Brooke McLaughlin; Diane Kissell; Cassandra L Perry; Matthew Veerkamp; Kejian Zhang; Ingrid A Holm; Cynthia A Prows
Journal:  Pharmacogenomics       Date:  2017-07-26       Impact factor: 2.533

5.  In Different Voices: The Views of People with Disabilities about Return of Results from Precision Medicine Research.

Authors:  Maya Sabatello; Yuan Zhang; Ying Chen; Paul S Appelbaum
Journal:  Public Health Genomics       Date:  2020-04-15       Impact factor: 2.000

6.  Cases in Precision Medicine: Should You Participate in a Study Involving Genomic Sequencing of Your Patients?

Authors:  Paul S Appelbaum; Deborah F Stiles; Wendy Chung
Journal:  Ann Intern Med       Date:  2019-10-01       Impact factor: 25.391

7.  Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study.

Authors:  Julia Wynn; Josue Martinez; Jessica Bulafka; Jimmy Duong; Yuan Zhang; Codruta Chiuzan; Jain Preti; Maria L Cremona; Vaidehi Jobanputra; Abby J Fyer; Robert L Klitzman; Paul S Appelbaum; Wendy K Chung
Journal:  J Genet Couns       Date:  2017-11-22       Impact factor: 2.537

8.  Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Authors:  Jill O Robinson; Julia Wynn; Barbara Biesecker; Leslie G Biesecker; Barbara Bernhardt; Kyle B Brothers; Wendy K Chung; Kurt D Christensen; Robert C Green; Amy L McGuire; M Ragan Hart; Ida Griesemer; Donald L Patrick; Christine Rini; David Veenstra; Angel M Cronin; Stacy W Gray
Journal:  Genet Med       Date:  2019-06-13       Impact factor: 8.822

9.  Impact of numeracy preferences on information needs for genome sequencing results.

Authors:  Richard D Albrechtsen; Melody S Goodman; Jemar R Bather; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2020-09-25

10.  Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast Cancer.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Brian L Egleston; Kara N Maxwell; Laura DiGiovanni; Jamie Brower; Dominique Fetzer; Jill Bennett Gaieski; Amanda Brandt; Danielle McKenna; Jessica Long; Jacquelyn Powers; Jill E Stopfer; Katherine L Nathanson; Susan M Domchek
Journal:  JCO Precis Oncol       Date:  2018-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.